News Spark files revolutionary gene therapy with FDA Luxturna granted six-month priority review by FDA.
News Disappointment as government delays pharma-friendly policies Proposals fall short of ambitions of Accelerated Access Review.
News Amicus to file Fabry drug after FDA changes mind Regulator drops demand for further phase 3 trial.
News The curious case of Mylotarg: Pfizer's leukaemia drug set to... Mylotarg backed by advisers after withdrawal in 2010.
Events Partner Content Clinical Trial Supply East Coast 2017 The 15th Annual CTS East Coast event builds on last year’s conference, Arena’s biggest East Coast CTS event to date.
Patients Delivering the right behavioural ingredients for the moment,... Lirio's Dr Amy Bucher discusses the risks of the declining trust in healthcare institutions from a behavioural science perspective.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.
